Similar articles for PMID: 19401474

Year	Number of Results
2004	1
2006	5
2007	2
2008	9
2009	23
2010	9
2011	8
2012	9
2013	3
2014	4
2015	9
2016	7
2017	2
2018	4
2019	4
2020	4
2021	6
2022	6
2023	7
2024	0

1

Romiplostim management of immune thrombocytopenic purpura.

Ipema HJ, Jung MY, Lodolce AE. Ipema HJ, et al. Ann Pharmacother. 2009 May;43(5):914-9. doi: 10.1345/aph.1L643. Epub 2009 Apr 28. Ann Pharmacother. 2009. PMID: 19401474 Review.

2

Romiplostim in chronic immune thrombocytopenic purpura.

Cersosimo RJ. Cersosimo RJ. Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013. Clin Ther. 2009. PMID: 19843480 Review.

3

Romiplostim: a novel thrombopoiesis-stimulating agent.

Perreault S, Burzynski J. Perreault S, et al. Am J Health Syst Pharm. 2009 May 1;66(9):817-24. doi: 10.2146/ajhp080524. Am J Health Syst Pharm. 2009. PMID: 19386944 Review.

4

Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.

Meletis J, Katsandris A, Raptis SD, Mantzourani M. Meletis J, et al. Med Sci Monit. 2010 Aug;16(8):CS100-2. Med Sci Monit. 2010. PMID: 20671616

5

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Kuter DJ, et al. Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2. Lancet. 2008. PMID: 18242413 Clinical Trial.

6

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.

Jamali F, Lemery S, Ayalew K, Robottom S, Robie-Suh K, Rieves D, Pazdur R. Jamali F, et al. Oncology (Williston Park). 2009 Jul;23(8):704-9. Oncology (Williston Park). 2009. PMID: 19711585 Free article. Clinical Trial.

7

Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura.

Newland A. Newland A. Eur J Haematol Suppl. 2009 Mar;(71):20-5. doi: 10.1111/j.1600-0609.2008.01209.x. Eur J Haematol Suppl. 2009. PMID: 19200304 Review.

8

Romiplostim: a review of its use in immune thrombocytopenia.

Keating GM. Keating GM. Drugs. 2012 Feb 12;72(3):415-35. doi: 10.2165/11208260-000000000-00000. Drugs. 2012. PMID: 22316355 Review.

9

Review article: second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults.

Lam MS. Lam MS. J Oncol Pharm Pract. 2010 Jun;16(2):89-103. doi: 10.1177/1078155209337668. Epub 2009 Jun 12. J Oncol Pharm Pract. 2010. PMID: 19525300 Review.

10

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials.

Tarantino MD, Despotovic J, Roy J, Grainger J, Cooper N, Beam D, Raj A, Maschan A, Kim J, Eisen M. Tarantino MD, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28630. doi: 10.1002/pbc.28630. Epub 2020 Sep 9. Pediatr Blood Cancer. 2020. PMID: 32902132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year